
Ze'ev Ronai, Ph.D.
Research Assistant Professor(s)
Lab Website
Ze'ev Ronai's Research Focus
Ze'ev Ronai's Research Report
Ze'ev Ronai's Bio

Publications
The transcription factor ATF2 promotes melanoma metastasis by suppressing protein fucosylation.
Lau E, Feng Y, Claps G, Fukuda MN, Perlina A, Donn D, Jilaveanu L, Kluger H, Freeze HH, Ronai ZA
Sci Signal 2015 Dec 8 ;8(406):ra124
Regulation of glutamine carrier proteins by RNF5 determines breast cancer response to ER stress-inducing chemotherapies.
Jeon YJ, Khelifa S, Ratnikov B, Scott DA, Feng Y, Parisi F, Ruller C, Lau E, Kim H, Brill LM, Jiang T, Rimm DL, Cardiff RD, Mills GB, Smith JW, Osterman AL, Kluger Y, Ronai ZA
Cancer Cell 2015 Mar 9 ;27(3):354-69
The E3 ubiquitin ligase Siah2 contributes to castration-resistant prostate cancer by regulation of androgen receptor transcriptional activity.
Qi J, Tripathi M, Mishra R, Sahgal N, Fazli L, Ettinger S, Placzek WJ, Claps G, Chung LW, Bowtell D, Gleave M, Bhowmick N, Ronai ZA
Cancer Cell 2013 Mar 18 ;23(3):332-46
Melanoma-intrinsic NR2F6 activity regulates antitumor immunity.
Kim H, Feng Y, Murad R, Pozniak J, Pelz C, Chen Y, Dalal B, Sears R, Sergienko E, Jackson M, Ruppin E, Herlyn M, Harris C, Marine JC, Klepsch V, Baier G, Ronai ZA
Sci Adv 2023 Jul 7 ;9(27):eadf6621
Ubiquitin Ligases Siah1a/2 Control Alveolar Macrophage Functions to Limit Carcinogen-Induced Lung Adenocarcinoma.
Scortegagna M, Du Y, Bradley LM, Wang K, Molinolo A, Ruppin E, Murad R, Ronai ZA
Cancer Res 2023 Jun 15 ;83(12):2016-2033
Inhibition of coronavirus HCoV-OC43 by targeting the eIF4F complex.
Feng Y, Grotegut S, Jovanovic P, Gandin V, Olson SH, Murad R, Beall A, Colayco S, De-Jesus P, Chanda S, English BP, Singer RH, Jackson M, Topisirovic I, Ronai ZA
Front Pharmacol 2022 ;13:1029093
NRF2 mediates melanoma addiction to GCDH by modulating apoptotic signalling.
Verma S, Crawford D, Khateb A, Feng Y, Sergienko E, Pathria G, Ma CT, Olson SH, Scott D, Murad R, Ruppin E, Jackson M, Ronai ZA
Nat Cell Biol 2022 Sep ;24(9):1422-1432
Author Correction: A systematic genome-wide mapping of oncogenic mutation selection during CRISPR-Cas9 genome editing.
Sinha S, Barbosa K, Cheng K, Leiserson MDM, Jain P, Deshpande A, Wilson DM 3rd, Ryan BM, Luo J, Ronai ZA, Lee JS, Deshpande AJ, Ruppin E
Nat Commun 2022 May 16 ;13(1):2828